Who owns the BIOZOL TRANSDERMAL SERUM trademark?

The BIOZOL TRANSDERMAL SERUM trademark is owned by Nexzol Pharma, Inc..

What class is the BIOZOL TRANSDERMAL SERUM trademark registered in?

The BIOZOL TRANSDERMAL SERUM trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for BIOZOL TRANSDERMAL SERUM?

The USPTO serial number for BIOZOL TRANSDERMAL SERUM is 87316486.

What is the registration number for BIOZOL TRANSDERMAL SERUM?

BIOZOL TRANSDERMAL SERUM is registered under USPTO registration number 6175489.

BIO

USPTO Trademark Record

REGISTERED

BIOZOL TRANSDERMAL SERUM

SN 87316486·Reg 6175489·Filed Jan 27, 2017

Owner Nexzol Pharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

BIOZOL TRANSDERMAL SERUM (Serial No. 87316486), Registration No. 6175489, is a registered US trademark filed on Jan 27, 2017 by Nexzol Pharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: October 14, 2030

Mark Intelligence

BIOZOL TRANSDERMAL SERUM (Reg. #6175489) is a registered US trademark that has been protecting its owner, Nexzol Pharma, Inc., since 2017. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 27, 2017

SERIAL

87316486

REG#

6175489

REGISTERED

Oct 13, 2020

Owner

Applicant

Nexzol Pharma, Inc.

Entity

Corporation

State

Address

1001 Avenida Pico, Suite C-501, San Clemente, CA, 92673

Country

Attorney

NameSean B. MacKenzie

Address

501 N. El Camino Real, Suite 200, SAN CLEMENTE, CA 92672, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 27, 2017

Serial Number87316486

Registration No.6175489

Registration DateOct 13, 2020

Status DateOct 13, 2020

Published for OppositionJul 04, 2017

Next RenewalOctober 14, 2030

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Aug 18, 2020

First use in commerce: Aug 18, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

45 events

TEAS SECTION 8 RECEIVED

Jul 17, 2026

TEAS SECTION 8 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Oct 13, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Oct 13, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 11, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 10, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Aug 24, 2020

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Aug 18, 2020

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Aug 18, 2020

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 08, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 5 GRANTED

Jan 07, 2020

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Dec 12, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Dec 12, 2019

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 26, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jul 24, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Jul 24, 2019

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Jul 24, 2019

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 28, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 26, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Feb 26, 2019

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Feb 26, 2019

SOU EXTENSION 3 GRANTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 07, 2019

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 31, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Aug 30, 2018

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Aug 23, 2018

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Aug 23, 2018

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 05, 2018

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 GRANTED

May 04, 2018

SOU EXTENSION 1 GRANTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 05, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

RESPONSE TO ITU OFFICE ACTION ENTERED

Mar 05, 2018

RESPONSE TO ITU OFFICE ACTION ENTERED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 09, 2018

CASE ASSIGNED TO INTENT TO USE PARALEGAL

ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST

Feb 09, 2018

ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST

SOU TEAS EXTENSION RECEIVED

Feb 05, 2018

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Feb 05, 2018

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 29, 2017

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 04, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Jul 04, 2017

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 14, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Apr 27, 2017

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 27, 2017

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 27, 2017

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 27, 2017

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 27, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Apr 24, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Jan 31, 2017

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 31, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

BIOZOL TRANSDERMAL SERUM

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Nexzol Pharma, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Sean B. MacKenzie

Resources

Company